Saccharomyces Boulardii

Description

Saccharomyces boulardii as a single named strain, with the CFU per capsule printed and no refrigeration required. The thing that sets Saccharomyces boulardii apart from everything else on this shelf is that it is not a bacterium at all. It is a yeast, which is why antibacterial antibiotics do not affect it, and why it is the one culture commonly taken during a course of them rather than afterwards.

What is on the panel

Why a yeast behaves differently from a bacterial culture

Lactobacilli and bifidobacteria are bacteria, and an antibiotic aimed at bacteria does not distinguish between the ones causing a problem and the ones in a capsule. A yeast is a different kingdom of life entirely, so the same drug has no effect on it. That single biological fact is the reason this organism has its own literature.

It also means the counting conventions are the same but the organism is not interchangeable with anything else on the gut health page. Findings on a lactobacillus do not transfer to a yeast any more than they transfer between bacterial strains.

What the trials administered

Published studies have mostly used 250 to 1,000 mg a day, roughly 5 to 20 billion CFU, over one to four weeks, with endpoints including diarrhoea incidence and duration, stool frequency counts and recurrence rates, frequently alongside an antibiotic course. Several reviews pooled those trials. That describes the amounts given and the measurements recorded in the literature, and it is not a claim about this bottle.

The caution that belongs near the top

There are published case reports of fungaemia involving Saccharomyces boulardii in people who are severely immunocompromised or who have central venous catheters, which is the one genuine safety signal in the literature on this organism. Anyone in either of those situations should not take a yeast culture without a clinician’s involvement. That sentence is more useful than anything else on this page.

Saccharomyces boulardii against a bacterial blend

They answer different questions and the choice is usually about timing. A bacterial blend taken during an antibacterial course is partly working against the drug. Saccharomyces boulardii is not, because the drug has no mechanism against a yeast. That is the practical distinction, and both formats sit on the same shelf with their counts printed individually.

Count at manufacture against count at expiry

Dried organisms die off through shelf life, so a bottle guaranteeing its number only at the moment of filling is answering an easier question than ours. The figure here holds to the expiration date under the storage conditions printed on the label. A smaller honest number beats a larger meaningless one.

Why no refrigeration

Lyophilised Saccharomyces boulardii is more tolerant of ambient temperature and humidity than most freeze dried bacterial cultures, which is a handling advantage rather than a measure of quality. It survives a warm delivery van. It does not survive a windowsill in August, and the guaranteed count assumes sensible storage.

Single strain, and why the number is on the label

With one organism, the count on the front belongs to that organism. In a ten strain blend quoting one total, the individual figures are gone, which is the mechanism described in what a blend is allowed to leave out. Saccharomyces boulardii is sold here on its own for that reason.

Testing

Every lot goes to an independent laboratory for strain identity by genetic method, a plate count of the CFU figure, and screening for contaminating organisms and heavy metals. Under count lots are withdrawn and the failing report stays published. For the regulatory and evidence framing, the NIH probiotics fact sheet is free and detailed, and your certificate is linked above.